https://stock.noler.com/us/stock/trillium-therapeutics-inc https://stock.noler.com/us/stock/trillium-therapeutics-inc/accounts-payable https://stock.noler.com/us/stock/trillium-therapeutics-inc/accrued-liabilities-current https://stock.noler.com/us/stock/trillium-therapeutics-inc/accumulated-depreciation https://stock.noler.com/us/stock/trillium-therapeutics-inc/accumulated-other-comprehensive-income https://stock.noler.com/us/stock/trillium-therapeutics-inc/additional-paid-in-capital https://stock.noler.com/us/stock/trillium-therapeutics-inc/additional-paid-in-capital-ifrs-full https://stock.noler.com/us/stock/trillium-therapeutics-inc/additions-to-rightofuse-assets https://stock.noler.com/us/stock/trillium-therapeutics-inc/adjustments-for-decrease-increase-in-other-assets https://stock.noler.com/us/stock/trillium-therapeutics-inc/adjustments-for-decrease-increase-in-other-current-assets https://stock.noler.com/us/stock/trillium-therapeutics-inc/adjustments-for-decrease-increase-in-trade-account-receivable https://stock.noler.com/us/stock/trillium-therapeutics-inc/adjustments-for-deferred-tax-of-prior-periods https://stock.noler.com/us/stock/trillium-therapeutics-inc/adjustments-for-depreciation-and-amortisation-expense https://stock.noler.com/us/stock/trillium-therapeutics-inc/adjustments-for-depreciation-and-amortisation-expense-and-impairment-loss-reversal-of-impairment-loss-recognised-in-profit-or-loss https://stock.noler.com/us/stock/trillium-therapeutics-inc/adjustments-for-fair-value-gains-losses https://stock.noler.com/us/stock/trillium-therapeutics-inc/adjustments-for-increase-decrease-in-deferred-income https://stock.noler.com/us/stock/trillium-therapeutics-inc/adjustments-for-increase-decrease-in-other-current-liabilities https://stock.noler.com/us/stock/trillium-therapeutics-inc/adjustments-for-increase-decrease-in-trade-account-payable https://stock.noler.com/us/stock/trillium-therapeutics-inc/adjustments-for-interest-expense https://stock.noler.com/us/stock/trillium-therapeutics-inc/adjustments-for-share-based-payments https://stock.noler.com/us/stock/trillium-therapeutics-inc/adjustments-for-unrealised-foreign-exchange-losses-gains https://stock.noler.com/us/stock/trillium-therapeutics-inc/adjustments-noncash-items-to-reconcile-net-income-loss-to-cash-provided-by-used-in-operating-activities https://stock.noler.com/us/stock/trillium-therapeutics-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/trillium-therapeutics-inc/amounts-payable-related-party-transactions https://stock.noler.com/us/stock/trillium-therapeutics-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/trillium-therapeutics-inc/aoci https://stock.noler.com/us/stock/trillium-therapeutics-inc/applicable-tax-rate https://stock.noler.com/us/stock/trillium-therapeutics-inc/assets https://stock.noler.com/us/stock/trillium-therapeutics-inc/assets-noncurrent https://stock.noler.com/us/stock/trillium-therapeutics-inc/available-for-sale-debt-unrealized-gain-loss https://stock.noler.com/us/stock/trillium-therapeutics-inc/average-exercise-price-of-share-options-exercisable-in-share-based-payment-arrangement https://stock.noler.com/us/stock/trillium-therapeutics-inc/average-exercise-price-of-share-options-expired-in-share-based-payment-arrangement https://stock.noler.com/us/stock/trillium-therapeutics-inc/average-exercise-price-of-share-options-forfeited-in-share-based-payment-arrangement https://stock.noler.com/us/stock/trillium-therapeutics-inc/average-exercise-price-of-share-options-granted-in-share-based-payment-arrangement https://stock.noler.com/us/stock/trillium-therapeutics-inc/average-exercise-price-of-share-options-outstanding-in-share-based-payment-arrangement https://stock.noler.com/us/stock/trillium-therapeutics-inc/basic-and-diluted-earnings-loss-per-share https://stock.noler.com/us/stock/trillium-therapeutics-inc/capital-expenditures https://stock.noler.com/us/stock/trillium-therapeutics-inc/cash-and-cash-equivalents https://stock.noler.com/us/stock/trillium-therapeutics-inc/cash-and-equivalents https://stock.noler.com/us/stock/trillium-therapeutics-inc/cash-and-restricted-cash https://stock.noler.com/us/stock/trillium-therapeutics-inc/cash-cash-equivalents-and-short-term-investments https://stock.noler.com/us/stock/trillium-therapeutics-inc/cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/trillium-therapeutics-inc/cash-flow-breakdown https://stock.noler.com/us/stock/trillium-therapeutics-inc/cash-flows-from-used-in-financing-activities https://stock.noler.com/us/stock/trillium-therapeutics-inc/cash-flows-from-used-in-investing-activities https://stock.noler.com/us/stock/trillium-therapeutics-inc/cash-flows-from-used-in-operating-activities https://stock.noler.com/us/stock/trillium-therapeutics-inc/cash-flows-from-used-in-operations-before-changes-in-working-capital https://stock.noler.com/us/stock/trillium-therapeutics-inc/cash-flows-used-in-obtaining-control-of-subsidiaries-or-other-businesses-classified-as-investing-activities https://stock.noler.com/us/stock/trillium-therapeutics-inc/common-stock-value https://stock.noler.com/us/stock/trillium-therapeutics-inc/comprehensive-income https://stock.noler.com/us/stock/trillium-therapeutics-inc/comprehensive-income-ifrs-full https://stock.noler.com/us/stock/trillium-therapeutics-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/trillium-therapeutics-inc/current-accrued-expenses-and-other-current-liabilities https://stock.noler.com/us/stock/trillium-therapeutics-inc/current-assets https://stock.noler.com/us/stock/trillium-therapeutics-inc/current-assets-ifrs-full https://stock.noler.com/us/stock/trillium-therapeutics-inc/current-financial-assets-at-fair-value-through-profit-or-loss-classified-as-held-for-trading https://stock.noler.com/us/stock/trillium-therapeutics-inc/current-liabilities https://stock.noler.com/us/stock/trillium-therapeutics-inc/current-liabilities-ifrs-full https://stock.noler.com/us/stock/trillium-therapeutics-inc/current-prepaid-expenses https://stock.noler.com/us/stock/trillium-therapeutics-inc/current-tax-expense-income https://stock.noler.com/us/stock/trillium-therapeutics-inc/deferred-compensation-share-based-arrangements-liability-current https://stock.noler.com/us/stock/trillium-therapeutics-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/trillium-therapeutics-inc/deferred-tax-assets-in-process-research-and-development https://stock.noler.com/us/stock/trillium-therapeutics-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/trillium-therapeutics-inc/deferred-tax-assets-other https://stock.noler.com/us/stock/trillium-therapeutics-inc/deferred-tax-assets-tax-credit-carryforwards https://stock.noler.com/us/stock/trillium-therapeutics-inc/deferred-tax-assets-tax-credit-carryforwards-research https://stock.noler.com/us/stock/trillium-therapeutics-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/trillium-therapeutics-inc/deferred-tax-expense-income https://stock.noler.com/us/stock/trillium-therapeutics-inc/depreciation https://stock.noler.com/us/stock/trillium-therapeutics-inc/depreciation-and-amortization https://stock.noler.com/us/stock/trillium-therapeutics-inc/depreciation-rightofuse-assets https://stock.noler.com/us/stock/trillium-therapeutics-inc/description-of-expected-volatility-share-options-granted https://stock.noler.com/us/stock/trillium-therapeutics-inc/description-of-option-life-share-options-granted https://stock.noler.com/us/stock/trillium-therapeutics-inc/description-of-risk-free-interest-rate-share-options-granted https://stock.noler.com/us/stock/trillium-therapeutics-inc/due-to-related-parties-current https://stock.noler.com/us/stock/trillium-therapeutics-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/trillium-therapeutics-inc/effect-of-exchange-rate-changes-on-cash-and-cash-equivalents https://stock.noler.com/us/stock/trillium-therapeutics-inc/employee-related-liabilities-current https://stock.noler.com/us/stock/trillium-therapeutics-inc/equity https://stock.noler.com/us/stock/trillium-therapeutics-inc/equity-and-liabilities https://stock.noler.com/us/stock/trillium-therapeutics-inc/exchange-rate-effect-on-cash https://stock.noler.com/us/stock/trillium-therapeutics-inc/expected-dividend-as-percentage-share-options-granted https://stock.noler.com/us/stock/trillium-therapeutics-inc/expense-from-share-based-payment-transactions-with-employees https://stock.noler.com/us/stock/trillium-therapeutics-inc/expense-relating-to-variable-lease-payments-not-included-in-measurement-of-lease-liabilities https://stock.noler.com/us/stock/trillium-therapeutics-inc/fair-value-adjustment-of-warrants https://stock.noler.com/us/stock/trillium-therapeutics-inc/fair-value-assets-level-1-to-level-2-transfers-amount https://stock.noler.com/us/stock/trillium-therapeutics-inc/fair-value-assets-level-2-to-level-1-transfers-amount https://stock.noler.com/us/stock/trillium-therapeutics-inc/fair-value-liabilities-level-1-to-level-2-transfers-amount https://stock.noler.com/us/stock/trillium-therapeutics-inc/fair-value-liabilities-level-2-to-level-1-transfers-amount https://stock.noler.com/us/stock/trillium-therapeutics-inc/finance-costs https://stock.noler.com/us/stock/trillium-therapeutics-inc/finance-income https://stock.noler.com/us/stock/trillium-therapeutics-inc/finance-income-cost https://stock.noler.com/us/stock/trillium-therapeutics-inc/financing-cash-flow https://stock.noler.com/us/stock/trillium-therapeutics-inc/foreign-currency-transaction-gain-loss-before-tax https://stock.noler.com/us/stock/trillium-therapeutics-inc/foreign-currency-transaction-gain-loss-unrealized https://stock.noler.com/us/stock/trillium-therapeutics-inc/form-d-stocks https://stock.noler.com/us/stock/trillium-therapeutics-inc/gains-losses-on-exchange-differences-on-translation-recognised-in-profit-or-loss https://stock.noler.com/us/stock/trillium-therapeutics-inc/general-and-administrative-expense https://stock.noler.com/us/stock/trillium-therapeutics-inc/grants-receivable-current https://stock.noler.com/us/stock/trillium-therapeutics-inc/held-to-maturity-securities https://stock.noler.com/us/stock/trillium-therapeutics-inc/held-to-maturity-securities-current https://stock.noler.com/us/stock/trillium-therapeutics-inc/impairment-loss-recognised-in-profit-or-loss-intangible-assets-other-than-goodwill https://stock.noler.com/us/stock/trillium-therapeutics-inc/impairment-of-long-lived-assets-held-for-use https://stock.noler.com/us/stock/trillium-therapeutics-inc/income-tax https://stock.noler.com/us/stock/trillium-therapeutics-inc/income-tax-expense https://stock.noler.com/us/stock/trillium-therapeutics-inc/income-taxes-paid https://stock.noler.com/us/stock/trillium-therapeutics-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/trillium-therapeutics-inc/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/trillium-therapeutics-inc/increase-decrease-in-cash-and-cash-equivalents https://stock.noler.com/us/stock/trillium-therapeutics-inc/increase-decrease-in-prepaid-expense https://stock.noler.com/us/stock/trillium-therapeutics-inc/increase-decrease-in-receivables https://stock.noler.com/us/stock/trillium-therapeutics-inc/increase-decrease-through-conversion-of-convertible-instruments https://stock.noler.com/us/stock/trillium-therapeutics-inc/increase-decrease-through-exercise-of-warrants-equity https://stock.noler.com/us/stock/trillium-therapeutics-inc/increase-decrease-through-share-based-payment-transactions https://stock.noler.com/us/stock/trillium-therapeutics-inc/increase-decrease-through-transactions-with-owners https://stock.noler.com/us/stock/trillium-therapeutics-inc/insider-transactions-preferred https://stock.noler.com/us/stock/trillium-therapeutics-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/trillium-therapeutics-inc/insider-transactions-stock-units https://stock.noler.com/us/stock/trillium-therapeutics-inc/insider-transactions-warrants https://stock.noler.com/us/stock/trillium-therapeutics-inc/intangible-assets-net-excluding-goodwill https://stock.noler.com/us/stock/trillium-therapeutics-inc/intangible-assets-other-than-goodwill https://stock.noler.com/us/stock/trillium-therapeutics-inc/interest-expense-on-lease-liabilities https://stock.noler.com/us/stock/trillium-therapeutics-inc/interest-receivable https://stock.noler.com/us/stock/trillium-therapeutics-inc/interest-receivable-current https://stock.noler.com/us/stock/trillium-therapeutics-inc/investing-cash-flow https://stock.noler.com/us/stock/trillium-therapeutics-inc/investment-income-interest https://stock.noler.com/us/stock/trillium-therapeutics-inc/issue-of-equity https://stock.noler.com/us/stock/trillium-therapeutics-inc/issued-capital https://stock.noler.com/us/stock/trillium-therapeutics-inc/key-management-personnel-compensation https://stock.noler.com/us/stock/trillium-therapeutics-inc/key-management-personnel-compensation-share-based-payment https://stock.noler.com/us/stock/trillium-therapeutics-inc/key-management-personnel-compensation-shortterm-employee-benefits https://stock.noler.com/us/stock/trillium-therapeutics-inc/lease-and-sublease-payments-recognised-as-expense https://stock.noler.com/us/stock/trillium-therapeutics-inc/lease-cost https://stock.noler.com/us/stock/trillium-therapeutics-inc/lease-liabilities https://stock.noler.com/us/stock/trillium-therapeutics-inc/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/trillium-therapeutics-inc/level-3-asset-transfers-net https://stock.noler.com/us/stock/trillium-therapeutics-inc/level-3-liability-transfers-net https://stock.noler.com/us/stock/trillium-therapeutics-inc/liabilities https://stock.noler.com/us/stock/trillium-therapeutics-inc/liabilities-noncurrent https://stock.noler.com/us/stock/trillium-therapeutics-inc/marketable-securities-current https://stock.noler.com/us/stock/trillium-therapeutics-inc/maturities-of-available-for-sale-securities https://stock.noler.com/us/stock/trillium-therapeutics-inc/maturities-of-held-to-maturity-securities https://stock.noler.com/us/stock/trillium-therapeutics-inc/net-change-in-cash https://stock.noler.com/us/stock/trillium-therapeutics-inc/net-income https://stock.noler.com/us/stock/trillium-therapeutics-inc/noncurrent-assets https://stock.noler.com/us/stock/trillium-therapeutics-inc/noncurrent-liabilities https://stock.noler.com/us/stock/trillium-therapeutics-inc/noncurrent-payables https://stock.noler.com/us/stock/trillium-therapeutics-inc/number-of-outstanding-share-options https://stock.noler.com/us/stock/trillium-therapeutics-inc/number-of-share-options-exercisable-in-share-based-payment-arrangement https://stock.noler.com/us/stock/trillium-therapeutics-inc/number-of-share-options-expired-in-share-based-payment-arrangement https://stock.noler.com/us/stock/trillium-therapeutics-inc/number-of-share-options-forfeited-in-share-based-payment-arrangement https://stock.noler.com/us/stock/trillium-therapeutics-inc/number-of-share-options-granted-in-share-based-payment-arrangement https://stock.noler.com/us/stock/trillium-therapeutics-inc/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax https://stock.noler.com/us/stock/trillium-therapeutics-inc/oci-foreign-currency-translation-adjustment-tax https://stock.noler.com/us/stock/trillium-therapeutics-inc/oci-net-of-tax https://stock.noler.com/us/stock/trillium-therapeutics-inc/oci-net-of-tax-exchange-differences-on-translation https://stock.noler.com/us/stock/trillium-therapeutics-inc/operating-cash-flow https://stock.noler.com/us/stock/trillium-therapeutics-inc/operating-expense https://stock.noler.com/us/stock/trillium-therapeutics-inc/operating-expenses https://stock.noler.com/us/stock/trillium-therapeutics-inc/operating-income https://stock.noler.com/us/stock/trillium-therapeutics-inc/operating-lease-assets https://stock.noler.com/us/stock/trillium-therapeutics-inc/operating-lease-liability https://stock.noler.com/us/stock/trillium-therapeutics-inc/operating-lease-liability-current https://stock.noler.com/us/stock/trillium-therapeutics-inc/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/trillium-therapeutics-inc/operating-lease-payments https://stock.noler.com/us/stock/trillium-therapeutics-inc/operating-lease-payments-due https://stock.noler.com/us/stock/trillium-therapeutics-inc/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/trillium-therapeutics-inc/operating-lease-payments-due-year-four https://stock.noler.com/us/stock/trillium-therapeutics-inc/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/trillium-therapeutics-inc/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/trillium-therapeutics-inc/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/trillium-therapeutics-inc/operating-leases-rent-expense-net https://stock.noler.com/us/stock/trillium-therapeutics-inc/operating-loss-carryforwards https://stock.noler.com/us/stock/trillium-therapeutics-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/trillium-therapeutics-inc/other-current-liabilities https://stock.noler.com/us/stock/trillium-therapeutics-inc/other-income https://stock.noler.com/us/stock/trillium-therapeutics-inc/other-noncurrent-assets https://stock.noler.com/us/stock/trillium-therapeutics-inc/other-noncurrent-liabilities https://stock.noler.com/us/stock/trillium-therapeutics-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/trillium-therapeutics-inc/payments-of-lease-liabilities-classified-as-financing-activities https://stock.noler.com/us/stock/trillium-therapeutics-inc/payments-to-acquire-available-for-sale-debt https://stock.noler.com/us/stock/trillium-therapeutics-inc/payments-to-acquire-held-to-maturity-securities https://stock.noler.com/us/stock/trillium-therapeutics-inc/prepaid-expense-current https://stock.noler.com/us/stock/trillium-therapeutics-inc/pretax-income https://stock.noler.com/us/stock/trillium-therapeutics-inc/proceeds-from-issuance-of-warrants https://stock.noler.com/us/stock/trillium-therapeutics-inc/proceeds-from-issuing-other-equity-instruments https://stock.noler.com/us/stock/trillium-therapeutics-inc/proceeds-from-issuing-shares https://stock.noler.com/us/stock/trillium-therapeutics-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/trillium-therapeutics-inc/proceeds-from-warrant-exercises https://stock.noler.com/us/stock/trillium-therapeutics-inc/profit-loss https://stock.noler.com/us/stock/trillium-therapeutics-inc/profit-loss-before-tax https://stock.noler.com/us/stock/trillium-therapeutics-inc/profit-loss-from-operating-activities https://stock.noler.com/us/stock/trillium-therapeutics-inc/profit-loss-ifrs-full https://stock.noler.com/us/stock/trillium-therapeutics-inc/property-plant-and-equipment https://stock.noler.com/us/stock/trillium-therapeutics-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/trillium-therapeutics-inc/property-plant-equipment https://stock.noler.com/us/stock/trillium-therapeutics-inc/public-float https://stock.noler.com/us/stock/trillium-therapeutics-inc/purchase-obligation-future-minimum-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/trillium-therapeutics-inc/purchase-of-property-plant-and-equipment-classified-as-investing-activities https://stock.noler.com/us/stock/trillium-therapeutics-inc/receivables-net-current https://stock.noler.com/us/stock/trillium-therapeutics-inc/rent-deferred-income-classified-as-noncurrent https://stock.noler.com/us/stock/trillium-therapeutics-inc/repayments-of-borrowings-classified-as-financing-activities https://stock.noler.com/us/stock/trillium-therapeutics-inc/repayments-of-notes-payable https://stock.noler.com/us/stock/trillium-therapeutics-inc/research-and-development https://stock.noler.com/us/stock/trillium-therapeutics-inc/research-and-development-expense https://stock.noler.com/us/stock/trillium-therapeutics-inc/retained-earnings https://stock.noler.com/us/stock/trillium-therapeutics-inc/retained-earnings-ifrs-full https://stock.noler.com/us/stock/trillium-therapeutics-inc/retention-payables https://stock.noler.com/us/stock/trillium-therapeutics-inc/revenue https://stock.noler.com/us/stock/trillium-therapeutics-inc/revenue-ifrs-full https://stock.noler.com/us/stock/trillium-therapeutics-inc/right-of-use-asset-obtained-in-exchange-for-operating-lease-liability https://stock.noler.com/us/stock/trillium-therapeutics-inc/rightofuse-assets https://stock.noler.com/us/stock/trillium-therapeutics-inc/sga-expense https://stock.noler.com/us/stock/trillium-therapeutics-inc/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-exercisable-options-average-exercise-price https://stock.noler.com/us/stock/trillium-therapeutics-inc/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-number-of-exercisable-options https://stock.noler.com/us/stock/trillium-therapeutics-inc/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-number-of-outstanding-options https://stock.noler.com/us/stock/trillium-therapeutics-inc/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-outstanding-options-average-exercise-price-beginning-balance https://stock.noler.com/us/stock/trillium-therapeutics-inc/shareholders-equity https://stock.noler.com/us/stock/trillium-therapeutics-inc/shares-issued https://stock.noler.com/us/stock/trillium-therapeutics-inc/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/trillium-therapeutics-inc/stock-award-options-expirations-in-period-average-exercise-price https://stock.noler.com/us/stock/trillium-therapeutics-inc/stock-award-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/trillium-therapeutics-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/trillium-therapeutics-inc/stock-based-compensation https://stock.noler.com/us/stock/trillium-therapeutics-inc/stock-compensation-unrecognized-cost-stock-options https://stock.noler.com/us/stock/trillium-therapeutics-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/trillium-therapeutics-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/trillium-therapeutics-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/trillium-therapeutics-inc/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/trillium-therapeutics-inc/stock-options-exercisable-intrinsic-value https://stock.noler.com/us/stock/trillium-therapeutics-inc/stock-options-exercisable-number https://stock.noler.com/us/stock/trillium-therapeutics-inc/stock-options-expirations-in-period https://stock.noler.com/us/stock/trillium-therapeutics-inc/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/trillium-therapeutics-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/trillium-therapeutics-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/trillium-therapeutics-inc/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/trillium-therapeutics-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/trillium-therapeutics-inc/tax-expense-income-at-applicable-tax-rate https://stock.noler.com/us/stock/trillium-therapeutics-inc/total-assets https://stock.noler.com/us/stock/trillium-therapeutics-inc/total-liabilities https://stock.noler.com/us/stock/trillium-therapeutics-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/trillium-therapeutics-inc/trade-and-other-current-payables https://stock.noler.com/us/stock/trillium-therapeutics-inc/trade-and-other-current-payables-to-related-parties https://stock.noler.com/us/stock/trillium-therapeutics-inc/trade-and-other-current-payables-to-trade-suppliers https://stock.noler.com/us/stock/trillium-therapeutics-inc/trade-and-other-current-receivables https://stock.noler.com/us/stock/trillium-therapeutics-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/trillium-therapeutics-inc/unused-tax-credits-for-which-no-deferred-tax-asset-recognised https://stock.noler.com/us/stock/trillium-therapeutics-inc/unused-tax-losses-for-which-no-deferred-tax-asset-recognised https://stock.noler.com/us/stock/trillium-therapeutics-inc/variable-lease-cost https://stock.noler.com/us/stock/trillium-therapeutics-inc/warrants-and-rights-outstanding https://stock.noler.com/us/stock/trillium-therapeutics-inc/weighted-average-number-of-share-outstanding-basic-and-diluted https://stock.noler.com/us/stock/trillium-therapeutics-inc/weighted-average-remaining-contractual-life-of-outstanding-share-options https://stock.noler.com/us/stock/trillium-therapeutics-inc/weighted-average-share-price-share-options-granted https://stock.noler.com/us/stock/trillium-therapeutics-inc/weighted-average-shares